WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'6301 Infant (under 12 months) mortality rate: 192
GDP / capita (US$): 6'4121 Child (under 5 years) mortality rate: 222

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 499  494  491  488  486  442  352  302 
Births 10  10  10  10  10  13  14  13 
Surviving infants 10  10  10  10  10  12  13  12 
Pop. less than 5 years 48  49  49  50  51  62  63  52 
Pop. less than 15 years 147  150  152  155  160  185  160  139 
Female 15-49 years 135  134  133  131  130  109  77  71 

Number of reported case

(Click for retrospective incidence data for Cabo Verde)
Diphtheria
Japanese encephalitis
Measles 1'279 
Mumps 11  40  198  42 
Pertussis 18  290 
Polio* 56  17 
Rubella 18  10  28  11'329 
Rubella (CRS) 16  46 
Tetanus (neonatal)
Tetanus (total) 40 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Cabo Verde)
Vaccine year result method % card seen                                                
BCG 2010  100  EPI   98  94  100  99  100  76  92  97 
DTP1 2010  100  EPI   98  93  98  99  100  73  93 
DTP3 2010  100  EPI   98  93  94  90  100  74  86  88 
HepB_BD          94  100  99  100  76 
HepB3 2010  98  EPI   98  93  94  90  98  73 
Hib3          93  94  90 
JapEnc         
MCV 2010  97  EPI   98  91  91  96  97  72  80  79 
MCV2          89  99 
PCV1         
PCV3         
Pol3 2010  100  EPI   98  93  94  90  100  74  86  87 
Rota1         
Rota_last         
Rubella1          89  99 
TT2plus 1997  38       63  64  45  90 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Cabo Verde)
BCG 94  99  99  99  99  96  97 
DTP1 93  98  99  99  99  94  96 
DTP3 93  94  90  99  99  90  88 
HepB3 93  94  90  98  98 
HepB_BD 94  99  99  99  91 
Hib3 93  94  90 
MCV 91  91  96  97  97  86  79 
MCV2 89  94  99 
PAB 92  92  92  92  78  60  75 
PnC3
Pol3 93  94  90  99  99  90  87 
Rota_last
YFV

Number of districts in the country 22  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 68
From 80 to 89% 14
From 50 to 79% 18
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepB birth; Yes
MMR 15 months; Yes
Measles 9 months; Yes
OPV birth; 2, 4, 6, 18 months; Yes
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes and CBAW

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  Yes  Yes  Yes  Yes 
What years does the MYP cover? number       2006-2010  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 22  22  17  17 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No       

System performance

Total Nº districts in country number 22  22  22  22  22  17  17 
Nº districts with DTP3 coverage >=80% number 18  21 
% of districts with DTP3 coverage >=80% From 0 to 100% 82  95  41  12 
Nº districts with measles (MCV1) coverage >=95% number 11         
% of districts with MCV1 coverage >=95% From 0 to 100% 50  41        24   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  No  No  No 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100    100  100  84  84  90 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.